2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies.

C. Jacquelinet,¹ B. Audry,¹ C. Antoine,¹ C. Suberbielle,² D. Glotz,² A. Tambur.³
HCC and Cardiac Cirrhosis After the Fontan Procedure in a Patient with Congenital Heart Disease and Situs Inversus.

P. Nguyen, N. Galvan, M. Kueht, C. O'Mahony, R. Cotton, A. Rana, J. Goss.
HCC and Liver Transplantation Following the Recent Allocation Policy Change.

T. Ishaque, A. Massie, M. Bowring, J. Ruck, A. Cameron, B. Philosophe, D. Segev.
HCV Eradication with DAA Therapy Should Be Attempted Prior to Liver Transplantation and Does Not Impact HCC Recurrence.

J. Emamaullee, M. Bral, G. Meeberg, A. Montano-Loza, V. Bain, D. Bigam, N. Kneteman, A. Shapiro.
HCV+ Waitlist Candidates More Likely to Die Waiting for Kidney Transplant from HCV- Donor.

B. Shelton,¹ D. Sawinski,² S. Mehta,¹ R. Reed,¹ P. MacLennan,¹ J. Locke.¹
Health Literacy, Functional Status and Transplant Eligibility Among Adult Liver Transplant Candidates.

M. Serper, K. Dwinnells, M. Wolf, K. Olthoff.
Healthcare Resource Utilization for Patients with Donor-Specific Antibodies Post-Kidney Transplantation.

B. Ho,¹ H. Bhagat,² E. Lee,^2,3 K. Atiemo,¹ A. Daud,¹ R. Kang,¹ S. Montag,^1,4 L. Zhao,^1,4 J. Schwartz,² D. Ladner.¹
Heat Shock Protein 90 Inhibitor, 17DMAG Suppresses Acute Allograft Rejection and Prolongs Allograft Survival in Solid Organ Transplantation.

T. Maehana, T. Tanaka, N. Masumori.
Hepatic Artery and Biliary Complications in Liver Transplant Recipients with Radioembolization Bridging Treatment for Hepatocellular Carcinoma.

S. Radunz,¹ J. Treckmann,¹ F. Saner,¹ S. Müller,² J. Theysohn,³ A. Paul,¹ T. Benkö.¹
Hepatic Ischemia Reperfusion Injury After Liver Transplantation Is Associated with Acute Kidney Injury.

S. Kubal,¹ M. Anderson,² J. Fridell,¹ B. Ekser,¹ T. Taber,² P. Li,¹ M. Ghabril,³ M. Lacerda,³ R. Mangus.¹
Hepatitis B Virus Infection Is Associated with Recurrent Nephropathy After Kidney Transplantation.

G. Chen, C. Wang, Z. Wu, C. Wang, J. Qiu, L. Chen.
Hepatitis C Genotypes Among Deceased Organ Donors in the United States.

D. Goldberg,¹ V. Van Deerlin,¹ M. Farooqi,¹ A. Sicilia,¹ R. Hasz,² R. Bloom,¹ E. Blumberg,¹ C. Gentile,¹ P. Abt,¹ P. Reese.¹
Hepatitis E Virus-Associated Cryoglobulinemia in Solid-Organ-Transplant Recipients: A Prospective Study.

O. Marion,¹ F. Abravanel,² L. Esposito,¹ S. Lhomme,² A. Del Bello,¹ J. Izopet,² N. Kamar.¹
Heterotopic Auxiliary Liver Transplantation(ALTx) – Revisited.

V. Kirchner, E. Minja, S. Chinnakotla, R. Kandaswamy, W. Payne, T. Pruett.
High CTLA-4 Expression and Diminished FOXO3 Expression Underlie Differential CD28 Signaling on Human Memory Th17 Cells.

S. Krummey,¹ S. Suchard,¹ S. Nadler,² C. Larsen,² M. Ford.¹
High Eomesodermin Expression Correlates with Potent Human Allo-Reactive CD8⁺ Effector T Cells.

A. Perez-Gutierrez, D. Metes, Y. Ono, A. Thomson, M. Ezzelarab.
High Mortality in Transplant Recipients Associated with Coccidioidomycosis Derived from Organ Donors.

N. Jeyakumar,² N. Neidlinger,³ M. Salvatore,³ C. Brown,⁴ T. Carpenter,³ M. Fung,¹ P. Chin-Hong.¹
High Regulatory T Cells Rate Early After Lung Transplantation Is Associated with Bronchiolitis Obliterans Syndrome Development.

M. Durand,^1,2 P. Lacoste,^2,3 C. Brosseau,^1,3 E. Durand,³ J. Loy,³ K. Henrio,^2,3 R. Danger,¹ P. Royer,³ A. Fourreau,³ A. Magnan,^3,4 S. Brouard.¹
High Risk Renal Transplant Recipients on Steroid Free Immunosupression Regimen. Indiana University Experience.

O. Adebiyi, S. Hussain, D. Mishler, W. Goggins, M. Yaqub, T. Taber, A. Sharfuddin.
High Titer De Novo Donor-Specific HLA Alloantibodies and Cardiac Allograft Vasculopathy After Pediatric Heart Transplantation.

B. Das,¹ S. Zhang,² A. Gao,² C. Lacelle.³
High-Dose Acyclovir for Cytomegalovirus Prevention in Seropositive Solid Organ Transplant Recipients.

J. Fose,¹ E. McCreary,¹ M. Jorgenson,¹ M. Lucey,² J. Smith.²
High-Risk Human Papillomavirus Associated with Genital Squamous Cell Carcinoma in Nonwhite Organ Transplant Recipients.

K. Nadhan,¹ M. Larijani,¹ L. Ogrich,¹ C. Shaver,¹ A. Doyle,² C. Chung.¹
Higher Mortality Among Candidates Who Refuse to Accept DCD Kidney Offers.

M. Bowring, A. Massie, D. Segev.
Higher Mortality Among Candidates Who Refused Increased-Infectious Risk Kidney Offers.

M. Bowring, L. Kucirka, A. Massie, C. Holscher, D. Segev.
Higher Tacrolimus Blood Levels Predict Better Graft Survival in Kidney Recipients with De Novo DSA.

M.-A. Béland,¹ R. Noël,¹ I. Côté,¹ I. Lapointe,¹ E. Wagner,² J. Riopel,³ E. Latulippe,³ O. Désy,¹ S. Béland,¹ I. Houde,¹ S. De Serres.¹
Highly Sensitized Patients and the Association of Early Cardiovascular Disease: Analysis of Korean Organ Transplantation Registry(KOTRY) Data.

J. Jeong,¹ J. Yang,² M. Kim,³ S. Shin,⁴ B. Chung,⁵ S. Han,⁶ C. Ahn.⁷
Hispanic Paradox in Patients with Liver Cirrhosis.

K. Atiemo, J. Caicedo, D. Ganger, E. Gordon, L. Zhao, S. Montag, H. Maddur, L. VanWagner, L. Kulik, S. Flamm, S. Goel, A. Kho, R. Kang, M. Abecassis, D. Ladner.
Histone Deacetylase Inhibition Mitigates Liver Ischemia/Reperfusion Injury in Mice.

D. Murken,¹ D. Aufhauser Jr,¹ S. Concors,¹ Z. Wang,¹ G. Ge,¹ W. Hancock,² M. Levine.¹
Histone Methyltransferase EZH2 Was Involved in the Mechanism of let-7e Inhibition of TNF-α Expression.

J. Huang,^1,2,3 Y. Zhang,^1,2,3 Q. Zhang,^1,2,3 L. Gui,^1,2,3 Y. Cai,^1,2,3 X. Deng.^1,2,3
HIV and Cognitive Impairment in Kidney Transplant Candidates.

A. Shaffer, H. Ying, C. Haugen, M. McAdams DeMarco, D. Segev.
HLA Alloimmunization According to the Different Immunization Events and Consequences on Access to Kidney Transplantation.

V. Pernin,¹ A. Cros,¹ I. Szwarc,¹ C. Rene,² J.-F. Eliaou,² V. Garrigue,¹ G. Mourad,¹ M. Le Quintrec-Donnette.¹
HLA Class II Molecules Partner with TLR4 to Stimulate Endothelial Cell Activation and Proliferation.

Y.-P. Jin, E. Reed.
HLA Donor-Specific Antibody (DSA) Negative Antibody-Mediated Rejection (AMR): Incidence, Treatment and Outcomes.

R. Redfield, S. Parajuli, W. Zhong, B. Astor, A. Djamali, D. Mandelbrot.
HLA Eplet Mismatches Predict DSA Formation, Graft Survival, and Re-Transplantation Rate in Pediatric Renal Transplantation.

M. Sypek,^1,2 S. Hiho,³ L. Cantwell,³ P. Hughes,² A. Le Page,⁴ J. Kausman.¹
HLA Mismatching Does Not Have an Impact on Graft or Patient Survival in Simultaneous Kidney-Pancreas Transplantation. A Single Institution Experience.

I. Moinuddin, M. Yaqub, T. Taber, D. Mishler, M. Mujtaba, J. Powelson, O. Adebiyi, J. Fridell, A. Sharfuddin.
HLA-C Mismatching and Humoral Alloimmune Responses in Pediatric Kidney Recipients with Subclinical Vascular Injury.

M. Seifert, M. Yanik, V. Hauptfeld-Dolejsek, R. Mannon.
HLA-DPA1 and HLA-DPB1 Frequencies in the US Populations.

Z. Du, J. Patel, C. Braun, B. Norton.
HLA-DR Based Murine Transplant Model for Studying Collagen Type V Autoimmunity in Chronic Allograft Rejection.

V. Agashe, Y. Zhou, E. Jankowska-Gan, W. Burlingham.
HLA, ANA, and ANCA Negative Vasculitis in Lung Transplantation Due to Overexpression of α1 Collagen V.

E. Daoud,¹ Y. Butt,¹ F. Torres,² T. Jose.¹
HOPE Act – The First Year.

A. Wilk, S. Taranto, R. Urban, D. Klassen.
Host-Derived, Intragraft Dendritic Cells Are Extensively Cross-Dressed by Donor MHC.

A. Hughes, H. Dai, A. Williams, M. Oberbarnscheidt, A. Morelli, F. Lakkis.
How Much Is a Kidney Worth? Comparing Kidney Transplant Strategies in Liver Transplant Candidates.

X. Cheng,¹ W. Kim,² J. Tan,¹ J. Goldhaber-Fiebert.³
How Potential Living Kidney Donors (LKDs) View ESRD Risk: A Multi-Center Study.

C. Thiessen,¹ G. Gannon,¹ D. Gray,² K. Kennedy,³ D. Dobosz,¹ S. Li,¹ K. Yu,¹ A. Mussell,² E. Gordon,³ P. Reese,² S. Kulkarni.¹
How to Improve Pre-Kidney Transplant Education for Hispanics: Preferences and Perceptions of Northwestern Memorial Hospital's Hispanic Transplant Program.

H. Gomez, E. Malagon-Blackwell, J. Caicedo.
How to Promote Regeneration After Ischemic Reperfusion Injury: Dual Role of CD 137 Agonistic Antibody.

J. Lee,^1,3 H. Kim,³ H. Chung,¹ K. Park,¹ B. Kwon,^3,4 H. Cho.^2,3
Human IL-10 Transfection of Porcine Lungs Significantly Increases IL-10 Levels in Vascular Perfusate During Human Blood Perfusion.

C. Laird,¹ L. Burdorf,¹ X. Cheng,¹ N. O'Neill,¹ S. Sendil,¹ D. Parsell,¹ M. Cypel,² C. Phelps,³ D. Ayares,³ A. Azimzadeh,¹ R. Pierson.¹
Human Islet-Derived Extracellular Vesicles Stimulate CD14+ Monocytes Resulting in Proinflammatory Cytokine Production.

A. Rutman, S. Negi, C. Hasilo, M. Gasparrini, J. Tchervenkov, S. Paraskevas.
Human Organs Allocated for Research – Maximising Use of a Precious Resource Using a New Ex Vivo Model of Reperfusion Injury.

B. Sandhu, H. Bishop, D. Loja, N. Galloway-Phillips, J. Crawley, C. Pusey, V. Papalois.
Human Regulatory T Cells Undergo Self-Inflicted Damage via Granzyme Pathways Upon Activation.

J. Assaker, E. Karreci, F. Dotiwala, S. Routray, A. Kurdi, A. Mihali, T. Borges, A. Chandraker, L. Riella, R. Abdi, J. Lieberman, J. Azzi.
Human Transitional B Cell Cytokine Profile Predicts Renal Allograft Rejection and Clinical Course.

A. Cherukuri, A. Sharma, R. Mehta, S. Hariharan, D. Rothstein.
Hurdles to Broader Implementation of the A₂/A₂BàB Deceased Donor Kidney Allocation Provision.

I. Kim,¹ A. Wilk,² A. Robinson,² P. Martins,³ V. Whitaker,⁴ E. Ward,² C. Miles.⁵
Hypogammaglobulinemia in Pediatric Heart Transplant Candidates Is Not Corrected by Transplantation.

R. Madan,¹ R. Penkert,² J. Dara,¹ J. Lamour,¹ B. Herold,¹ J. Hurwitz.²
Hypothermic Pulsatile Machine Perfusion for Human Pancreas Preservation.

J. Branchereau, K. Renaudin, D. Cantarovich.
Hypoxia Induces Tissue Factor Upregulation in Isolated Human Islets.

B. Sandhu,¹ M. Prendecki,¹ G. Rutter,¹ A. Martinez-Sanchez,¹ N. Kanda,¹ N. Galloway-Phillips,¹ R. Smith,² C. Pusey,¹ V. Papalois.¹

Jump to: View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z